Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124990912 | 12499091 | 2 | F | 2013 | 20160920 | 20160627 | 20160927 | EXP | CA-AMGEN-CANSP2016080246 | AMGEN | 71.00 | YR | E | F | Y | 0.00000 | 20160927 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124990912 | 12499091 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, QWEEK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | /wk | |||||
124990912 | 12499091 | 2 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | 20 MG, DAILY | 0 | 20 | MG | QD | |||||||
124990912 | 12499091 | 3 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | ||||||||||
124990912 | 12499091 | 4 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | UNK | 0 | ||||||||||
124990912 | 12499091 | 5 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | 200 MG, EVERY OTHER WEEK | 0 | 200 | MG | QOW | |||||||
124990912 | 12499091 | 6 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | 40 MG, EVERY OTHER WEEK | 0 | 40 | MG | QOW | |||||||
124990912 | 12499091 | 7 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | 500 MG, EVERY FOUR WEEKS | 0 | 500 | MG | ||||||||
124990912 | 12499091 | 8 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | 25 MG, QWK | 0 | 25 | MG | /wk | |||||||
124990912 | 12499091 | 9 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | 17.5 MG, QWEEK | 0 | 17.5 | MG | /wk | |||||||
124990912 | 12499091 | 10 | C | LEUCOVORIN. | LEUCOVORIN | 1 | UNK | 0 | |||||||||||
124990912 | 12499091 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 2000 IU, UNK | 0 | 2000 | IU | |||||||||
124990912 | 12499091 | 12 | C | COVERSYL | PERINDOPRIL | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124990912 | 12499091 | 1 | Rheumatoid arthritis |
124990912 | 12499091 | 2 | Product used for unknown indication |
124990912 | 12499091 | 3 | Product used for unknown indication |
124990912 | 12499091 | 4 | Rheumatoid arthritis |
124990912 | 12499091 | 5 | Product used for unknown indication |
124990912 | 12499091 | 6 | Product used for unknown indication |
124990912 | 12499091 | 7 | Product used for unknown indication |
124990912 | 12499091 | 8 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124990912 | 12499091 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124990912 | 12499091 | Affect lability | |
124990912 | 12499091 | Anxiety | |
124990912 | 12499091 | Finger deformity | |
124990912 | 12499091 | Foot operation | |
124990912 | 12499091 | Headache | |
124990912 | 12499091 | Hyperhidrosis | |
124990912 | 12499091 | Joint swelling | |
124990912 | 12499091 | Nausea | |
124990912 | 12499091 | Osteoarthritis | |
124990912 | 12499091 | Palpitations | |
124990912 | 12499091 | Rheumatoid arthritis | |
124990912 | 12499091 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124990912 | 12499091 | 1 | 200503 | 2013 | 0 | |
124990912 | 12499091 | 5 | 201311 | 201404 | 0 | |
124990912 | 12499091 | 6 | 201303 | 201309 | 0 | |
124990912 | 12499091 | 7 | 201405 | 20160606 | 0 | |
124990912 | 12499091 | 8 | 200210 | 0 | ||
124990912 | 12499091 | 9 | 201208 | 0 |